Assessment of Clinical Utility of Assaying FGF-23, Klotho Protein, Osteocalcin, NTX, and Sclerostin in Patients with Primary Hyperparathyroidism

Assessment of Clinical Utility of Assaying FGF-23, Klotho Protein, Osteocalcin, NTX, and Sclerostin in Patients with Primary Hyperparathyroidism

The purpose of this study was to assess the clinical usefulness of assaying the fibroblast growth factor (FGF-23), Klotho, osteocalcin, N-terminal telopeptide of type I collagen (NTX), and sclerostin levels in patients with primary hyperparathyroidism (PHPT) as markers of bone damage as well as for...

Full description

Bibliographic Details
Main Authors: Monika Sykała, Piotr Szumowski, Małgorzata Mojsak, Saeid Abdelrazek, Łukasz Żukowski, Danuta Lipińska, Ilona Juchnicka, Gabryela Kozłowska, Małgorzata Szelachowska, Adam Krętowski, Janusz Myśliwiec
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Journal of Clinical Medicine
Subjects:
primary hyperparathyroidism
parathyroid
parathyroidectomy
FGF-23
Klotho
osteocalcin
Online Access:https://www.mdpi.com/2077-0383/10/14/3089

Internet

https://www.mdpi.com/2077-0383/10/14/3089

Similar Items